Ahmed Hamdy
Vorstandsvorsitzender bei VINCERX PHARMA, INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Pablo D. T. Valenzuela | M | - |
Andes Biotechnologies Global, Inc.
 Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA.
Andes Biotechnologies SA
 Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 16 Jahre |
| Raquel Izumi | M | 54 | 8 Jahre | |
| Luis O. Burzio | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 16 Jahre |
| Laura Bushnell | F | 56 |
Baskin School of Engineering
| 5 Jahre |
| Richard Slavin | M | - |
The Palo Alto Medical Foundation
| - |
| Patricio Cáceres | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| Cristian Hernández-Cuevas | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| John Lee | M | 56 | 4 Jahre | |
| Brian Druker | M | 68 | 4 Jahre | |
| Francisco Salva | M | 53 | 4 Jahre | |
| Alexander Seelenberger Farba | M | 45 |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 15 Jahre |
| Ruth Stevens | M | 64 | 3 Jahre | |
| Soo In Hwang | M | 64 | 6 Jahre | |
| Tasheda Navarro | F | - | 3 Jahre | |
| Tom Thomas | M | 64 | 6 Jahre | |
| Jennifer Taubert | F | 60 | 19 Jahre | |
| Hans-Georg Lerchen | M | - | 3 Jahre | |
| Gonzalo Miranda | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| Bob S. Hu | M | - |
The Palo Alto Medical Foundation
| - |
| Bill Donaldson | M | - | - | |
| Melissa Merrick | F | - | 3 Jahre | |
| Amy Johnson | M | - | 3 Jahre | |
| Dominique Quincy | M | - |
The Palo Alto Medical Foundation
| - |
| Robert Jaunich | M | 84 |
The Palo Alto Medical Foundation
| - |
| Bernardita Méndez Velasco | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| Susan B. Ford-Dorsey | F | 69 |
The Palo Alto Medical Foundation
| - |
| Dan Maydan | M | 88 |
The Palo Alto Medical Foundation
| 21 Jahre |
| Peter L. Harris | M | 80 |
The Palo Alto Medical Foundation
| - |
| Sanjay Subhedar | M | - |
The Palo Alto Medical Foundation
| - |
| Michael R. Gaulke | M | 78 |
The Palo Alto Medical Foundation
| 37 Jahre |
| Jack S. Remington | M | 93 |
The Palo Alto Medical Foundation
| - |
| James Wilson | M | 80 |
The Palo Alto Medical Foundation
| - |
| InaMarie Johnson | F | 59 |
The Palo Alto Medical Foundation
| - |
| Elizabeth Dávila | F | 80 |
The Palo Alto Medical Foundation
| - |
| Elizabeth Vilardo | M | - |
The Palo Alto Medical Foundation
| 9 Jahre |
| Margaret A. Taylor | F | - |
The Palo Alto Medical Foundation
| - |
| Susan Ford Dorsey | F | - |
The Palo Alto Medical Foundation
| - |
| Martin Entwistle | M | - |
The Palo Alto Medical Foundation
| - |
| Paul Tang | M | - |
The Palo Alto Medical Foundation
| - |
| Elsa Johnson | F | - | - | |
| Elizabeth Forminard | F | 53 | 18 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ramses Erdtmann | M | 60 | 6 Jahre | |
| Richard Miller | M | 73 | 17 Jahre | |
| Robert Duggan | M | 79 | 7 Jahre | |
| Leiv Lea | M | 70 | 11 Jahre | |
| Mahkam Zanganeh | M | 52 | 7 Jahre | |
| Joseph Papa | M | 68 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 3 Jahre |
| Charles O. Prince | M | 74 | 17 Jahre | |
| Lisa Romanko | F | - | 19 Jahre | |
| Carla Sivak | F | - | 4 Jahre | |
| Minesh P. Mehta | M | 65 | - | |
| Richard van den Broek | M | 57 | 6 Jahre | |
| Glenn C. Rice | M | 68 | 2 Jahre | |
| Roy C. Hardiman | M | 64 | 2 Jahre | |
| Christopher Lowe | M | 56 | 2 Jahre | |
| Mark McCamish | M | 72 | 1 Jahre | |
| George Davy | M | 72 | 3 Jahre | |
| Jack Michelson | M | 89 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 11 Jahre |
| James A. Nash | M | 73 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | - |
| Catherine Klema | F | 65 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 9 Jahre |
| Andrew McDonald | M | 50 | 2 Jahre | |
| James N. Lowder | M | 74 | - | |
| David Duane Smith | M | 52 | - | |
| Michael Johns | M | 82 | 9 Jahre | |
| Robert Booth | M | 70 | - | |
| Eric Hedrick | M | 59 | 2 Jahre | |
| LaVerne Council | F | 62 | 5 Jahre | |
| Janis Smith-Gomez | F | 57 | 16 Jahre | |
| David Duerst | M | - | 11 Jahre | |
| Vanessa Broadhurst | F | 55 | 16 Jahre | |
| Desiree Ralls-Morrison | F | 57 | 8 Jahre | |
| Jabulani Mahange | M | 63 | 4 Jahre | |
| John A. Salvagno | M | - | 3 Jahre | |
| Denice Torres | F | 64 | 12 Jahre | |
| Craig Buchholz | M | - | 3 Jahre | |
| Richard C. Woodman | M | 69 | 4 Jahre | |
| Matt Roberts | M | 50 | - | |
| Natasha Kehimkar | F | - | 2 Jahre | |
| Joy Greer | M | - | 1 Jahre | |
| Yves Decadt | M | 57 | 5 Jahre | |
| Douglas K. Chia | M | - | - | |
| Sean Cao | M | - | 3 Jahre | |
| Elizabeth Cermak | F | 66 | - | |
| Rick Anderson | M | 63 | 9 Jahre | |
| Sandra B. Lawrence | F | 74 | 2 Jahre | |
| Tony Vernon | M | 69 | 23 Jahre | |
| John Onopchenko | M | 66 | 10 Jahre | |
| Helen E. Short | F | 74 | - | |
| Bridgette Heller | F | 62 | 5 Jahre | |
| Louise Mehrotra | F | - | 11 Jahre | |
| Henry B. Schacht | M | 89 | 8 Jahre | |
| Noël Jans | M | - | 1 Jahre | |
| John Orwin | M | 59 | 4 Jahre | |
| M. Judah Folkman | M | - | 7 Jahre | |
| Mark R. Straley | M | 63 | - | |
| David Shamis | M | - | 2 Jahre | |
| Gerard N. Burrow | M | - | 12 Jahre | |
| Gerald Ostrov | M | 73 | 15 Jahre | |
| Patrick J. O'Neill | M | 74 | 30 Jahre | |
| Jerry Chang | M | 65 | 8 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 95 | 95,00% |
| Chile | 7 | 7,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ahmed Hamdy
- Persönliches Netzwerk
